PeptideUniv

Retatrutide Peptide Guide

Retatrutide (LY3437943) is an investigational “triple agonist” (GLP-1, GIP, and glucagon receptor activity) being studied for obesity and metabolic outcomes. This page summarizes what’s promising, what’s uncertain, and what to watch for in the data—without hype or protocol instructions.

What is Retatrutide?

Retatrutide is a lab-designed peptide being studied for obesity and metabolic disease. It is engineered to act like incretins (GLP-1 and GIP) plus glucagon signaling. That combination can shift both food intake and how the body handles fuel.

Educational information only. Not medical advice.

Benefits

Mechanism of action

Primary pathways (studied):

Cell-level effects (studied):

System-level effects (studied):

Half-life

Half-life: Several days (long-acting), not fully established across populations.

Duration: Not fully established

Peak time: Not fully established

Storage

Storage depends on formulation (lyophilized powder vs reconstituted solution) and the manufacturer. Follow the product label when available.

Reconstitution guide

For measurement math (mg, mL, and U-100 units), use:

Protocol overview

Protocol pages summarize common research-style structures and measurement concepts. They do not provide individualized instructions.

Educational information only. Not medical advice.

Dosage and calculator

For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.